Compared with the T1DM, DR1 agonist SKF38393 significantly increased DR1 and CSE expression and endogenous H2S production, while NaHS (a H2S donor) only increased CSE expression and endogenous H2S production and had no effect on DR1 expression. The gene discussed is DR1; the disease is type 1 diabetes mellitus.